[go: up one dir, main page]

WO2008048780A1 - Procédé et appareil permettant de localiser un objet dans le corps - Google Patents

Procédé et appareil permettant de localiser un objet dans le corps Download PDF

Info

Publication number
WO2008048780A1
WO2008048780A1 PCT/US2007/080250 US2007080250W WO2008048780A1 WO 2008048780 A1 WO2008048780 A1 WO 2008048780A1 US 2007080250 W US2007080250 W US 2007080250W WO 2008048780 A1 WO2008048780 A1 WO 2008048780A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrodes
locations
electrical
estimating
electrical activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/080250
Other languages
English (en)
Inventor
Richard J. Cohen
Maya Barley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Priority to US12/445,668 priority Critical patent/US20100283484A1/en
Publication of WO2008048780A1 publication Critical patent/WO2008048780A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
    • A61B5/061—Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body
    • A61B5/063—Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body using impedance measurements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046—Tracking techniques
    • A61B2034/2051—Electromagnetic tracking systems
    • A61B2034/2053—Tracking an applied voltage gradient

Definitions

  • This invention relates to method and apparatus for the image guidance of invasive surgical and diagnostic tools, including but not limited to such procedures as organ biopsies, device implantation, and radiofrequency ablation.
  • MI surgery allows surgeons to diagnose and treat conditions with a minimum of the pain, discomfort, disability and morbidity that are more frequently due to the trauma involved in getting access to the surgical site than the procedure itself. For example, following a cholecystectomy, the need for hospitalization was not related to the removal of the gallbladder but rather was necessary because of the pain from the trauma to the abdominal wall caused by the incision to gain access to the gallbladder. [1] Numbers in square brackets refer to the references appended hereto, the contents of all of which are incorporated herein by reference. The concept of MI surgery has existed for almost a century [2], but the technology to make it possible on a wide scale was only developed in the late 20 th century. [3] Minimally-invasive surgical techniques are now used in many specialties including general surgery, plastic surgery, urology, thoracic surgery and cardiac surgery.
  • Ultrasonographic guidance provides real-time positional monitoring and does not entail potentially dangerous radiation exposure. Ultrasound equipment is also widely available. However, sonographically-guided surgery (especially in the case of surgical biopsy) often requires excellent hand-eye coordination because of the need to hold both the surgical instrument and the ultrasound transducer. [6] Furthermore, sonography can in some cases only image a subset of lesions. [7] As with x-ray guidance, the images are 2-D projections of 3-D instrument movement, potentially leading to inaccurate positioning. 3-D ultrasound imaging has recently been developed. Although excellent stereoscopically-displayed 3-D ultrasound images of breast tumors and cardiac structures have been demonstrated, image reconstruction cannot be done in real-time, and therefore this is not yet a viable guidance technology. [8]
  • MRI imaging equipment is real-time, 3-D, of high resolution, and is usually the most sensitive imaging modality for defining soft-tissue anatomic locations and lesion boundaries.
  • MRI imaging equipment must be present in the procedure room, such procedures are highly expensive and are limited to those hospitals or clinics with the necessary resources.
  • MRI imaging equipment is also bulky and unwieldy, restricting the space available to the surgical team.
  • the large magnetic fields require the use of special surgical instruments. [10] Therefore, a surgical guidance system is needed with 3-D imaging capability, sensitivity, real-time monitoring potential, safety, and low cost.
  • Breast biopsy is an excellent example of a common minimally-invasive procedure for which improvements in guidance mechanisms could lead to significant increases in accurate diagnosis and tumor excision.
  • Breast cancer is the second-leading cause of death from cancer in American women.
  • Breast cancer is diagnosed through biopsy of a suspicious lesion normally detected on palpation or through routine screening.
  • Mammography is the only screening test for breast cancer that has been extensively evaluated. Approximately one-quarter of all breast cancers occur in women below the age of 50, in younger patients the density of the breast parenchyma reduces the ability of mammography to detect lesions.
  • Breast biopsy conducted under stereotactic imaging is also of reduced accuracy in this subset of patients. Therefore in this patient sub-group, the prognosis is poor.
  • Contrast-enhanced MRI has a sensitivity of greater than 90% in the detection of breast cancer. [11] It is sensitive to small lesions and can successfully image dense breast tissue. Therefore, MRI is often used as a breast-cancer screening tool alongside mammography in high-risk younger women. [12] However, breast biopsy under MRI guidance suffers from the drawbacks detailed above, and is only used in high-risk women whose lesions cannot be imaged with any other imaging modality. A biopsy-guidance system that combines the sensitivity and 3-D imaging capability of MRI with the real-time monitoring potential and safety of ultrasound, and the low cost of sonography would be invaluable.
  • Radio-Frequency Ablation (RFA) of cardiac arrhythmias requires more complex guidance systems, due to the complexity of the cardiac structure, the movement of the beating heart, and the risk of life-threatening injury.
  • RPA Radio-Frequency Ablation
  • Several novel guidance systems have recently been developed; however, each of these has significant drawbacks. Improvements in guidance technology could lead to significant improvements in the accuracy of ablation and in the standard of living of those with ventricular arrhythmias.
  • CARTO uses a special catheter to generate 3-D electroanatomic cardiac maps, and is now widely used in RFA procedures.
  • a device external to the patient's body emits a very low magnetic field that is detected at the tip of the mapping and ablation catheter, and is used to sense its location and orientation relative to the magnetic field emitter.
  • the catheter tip simultaneously stimulates the cardiac tissue and records the resulting local electrocardiograms.
  • the amplitude of the local electrograms during sinus mapping, and the site at which they were recorded, are displayed in a 3-D electro-anatomical map that clearly delineates scar tissue.
  • the catheter tip is also displayed; the display is R-wave gated so that movement due to heart motion is cancelled.
  • CARTO has several drawbacks.
  • CARTO computed tomography
  • MRI magnetic resonance imaging
  • CartoMerge is a newly FDA-approved technology that aligns a pre-procedural cardiac CT or MRI image with the electroanatomic maps and real-time data generated by a traditional CARTO system.
  • the system tracks and displays the estimated real-time catheter tip location and orientation within the true cardiac anatomy.
  • the accuracy of image registration (the method by which CARTO data is mapped to the MRI image) is highly dependent on the location of the landmarks used in the registration and on the number of endocardial mapping points collected by the CARTO system. Furthermore, small errors in the acquisition of registration points may introduce significant registration error, especially at mapping points far from the registration landmarks.
  • the RealTime Position Management (RTM) system from Cardiac Pathways uses ultrasound to monitor the absolute position of the electrodes, ablation catheter, and the cardiac tissue itself. Like the CARTO system, it analyzes the electrical characteristics of the tissue at individual points. This information is then overlaid with the ultrasound images to create an electroanatomic map. Because the system indicates catheter position during mapping and allows recall of previous catheter positions, the catheter can be guided to a point on the map [14]. However, frequent failure of the ultrasound transducers, requiring catheter replacement, is a significant drawback. Furthermore, ultrasound has a far-lower resolution than either MRI or CT. Consequently, the electroanatomic map lacks fine detail that would assist in precise placement of the ablation catheter.
  • the LocaLisa positioning system is a non-fluoroscopic catheter positioning system that allows a conventional catheter to be located in three dimensions. Three orthogonal electric fields are generated across the body by sets of skin electrodes. For calibration purposes, the electrical field strength due to each applied current within the cardiac chamber of interest is first calculated. This is done automatically by measuring the amplitude difference for 3 different spatial orientations of the catheter tip between neighboring electrode pairs with a known inter-electrode distance. [15] Following calibration, the catheter can be freely moved within the chamber.
  • the 3- D position of the tip electrode relative to a surface reference electrode is then calculated: first, the amplitudes at the catheter tip due to the three orthogonal electric fields are measured relative to the surface reference electrode; then these three amplitudes are divided by their corresponding electrical field strength (as calculated during calibration).
  • LocaLisa has a significant advantage over competing systems that it requires no special catheters. It also reduces the patient and operator exposure to radiation during mapping. [16] However, stability of the surface reference electrode is vital to the accuracy of the system. Furthermore, this method falsely assumes a homogenous 3D electrical field within the entire body cavity. Consequently, errors at positions more than a few centimeters from the location of calibration may be on the order of 8 mm. The severity of these errors, and the measurement of the catheter position in co-ordinates relative to a reference point, prevents the positional data from being superimposed on a detailed image of the surgical region.
  • the present invention is able to localize an object within the body with respect to a three-dimensional, high resolution image acquired using one or more of these modalities.
  • This technology is also able to track the location of the object as it is moved.
  • the high-resolution image may be acquired before the start of the medical procedure, outside the operating room. Therefore, the use of limited hospital resources and the cost of the procedure will be significantly reduced.
  • the space available to the surgical team will not be limited by the presence of bulky MRI equipment.
  • this novel invention is safe to both patient and doctor, utilizes no special (and expensive) catheter equipment, and has high accuracy regardless of object location. As such, it promises a significant advancement in the field of localization and guidance technology, with applications across a wide range of surgical and diagnostic procedures.
  • the method and apparatus of this invention permits one to localize an object within the body with respect to a high resolution image of the region of the body.
  • the method of the invention for localizing an object in the body includes obtaining an image of a region of the body. This image is then used to estimate the electrical conductivity at a plurality of locations. A plurality of Body Electrodes are then applied to the body, and one or more objects containing one or more conducting Object Electrodes are introduced into the region of the body that was imaged. Electrical currents are then applied to the Body Electrodes and the electrical activity that results within the body is detected by the Object Electrodes and recorded. The recorded electrical activity is then used to estimate the locations of the one or more Object Electrodes.
  • MRI or CT or ultrasound is used to obtain images of the region of a body.
  • the electrical conductivity at a plurality of locations within this region of the body may be estimated by segmenting the images into tissue types and assigning conductivity values to each tissue -type.
  • the electrical conductivity at a plurality of locations within this region of the body may be estimated by correlating a characteristic of the image signal from each location with the conductivity of that location.
  • the image signal for example, might be the intensity of the signal in the case of ultrasound, relaxation time in the case of MRI, or x-ray density in the case of CT.
  • the electrical activity due to currents consecutively injected by the Body Electrodes is simulated at a plurality of locations. This simulated activity may then be stored. In one embodiment, the simulated electrical activity at a plurality of locations is compared with the electrical activity detected by the one or more Object Electrodes; the location with the 'most similar' simulated electrical activity to that detected by the one or more Object Electrodes may then be defined as the location of the Object Electrode. In a preferred embodiment of this invention, knowledge of the electrical activity detected by the one or more Object Electrodes is used to improve the accuracy of the simulation.
  • the locations of the one or more Object Electrodes are displayed on a graphical user interface.
  • the displayed locations of the one or more Object Electrodes may be superimposed on an image of a region of the body.
  • the object is repeatedly localized as the object is moved within the body.
  • the method of the invention for localizing an object in the body includes applying a plurality of electrodes to the body (Body Electrodes). An object containing one or more conducting electrodes (Object Electrodes) is then introduced into the body. Electrical currents with a frequency greater than 50 KHz (so as to reduce the electrical anisotropy of body tissues) are applied to the Body Electrodes and the electrical activity detected by the Object Electrodes is recorded. The locations of one or more Object Electrodes are then estimated using the recorded electrical activity.
  • FIG 1 is a flow chart of the method for localizing an object inside the body.
  • FIG 2 is a flow chart of a preferred embodiment of the method for localizing an object inside the body.
  • FIG 3 is a schematic diagram of an apparatus for localizing an object inside the body.
  • FIG 4 shows a simulation model that demonstrates a simple example of our method to localize an object in the volume conductor.
  • FIG 5 shows a horizontal (x-y) slice through the center of the simulated model, with the simulated voltage values for the voxels within that slice displayed on the z-axis.
  • FIG 6 is a flow chart of the method for localizing an object inside the body when the electrical currents that are applied to the Body Electrodes have a frequency of greater than 50 kHz.
  • the method includes obtaining an image of a region of the body. This image is then used to estimate the electrical conductivity at a plurality of locations. A plurality of Body Electrodes are then applied to the body, and one or more objects containing one or more conducting Object Electrodes are introduced into the region of the body that was imaged. Electrical currents are then applied to the Body Electrodes and the electrical activity that results within the body is detected by the Object Electrodes and recorded. The recorded electrical activity is then used to estimate the locations of the one or more Object Electrodes.
  • FIG. 2 shows a flowchart of a preferred embodiment of the method according to the present invention of localizing an object inside the body.
  • MRI or CT or ultrasound is used to obtain images of the region of a body.
  • the images encompass the surgical area of interest, and may provide full cross-sectional views of the region of the body. Images may be taken with a resolution on the order of 2 mm, so that each image 'voxel' is of dimension 2x2x2 mm; this figure is provided for the sake of illustration and is not intended to limit the scope of this disclosure.
  • the electrical conductivity at a plurality of locations within this region of the body may be estimated.
  • the anatomical images are processed to obtain an electrical conductivity value (Q -1 Cm "1 ) for each location.
  • a 'conductivity map' of the surgical area of interest is thus generated.
  • a location's conductivity value is determined primarily by the body tissue in which it is located. Therefore conductivity maps may be obtained by segmentation of the anatomical images into tissue types and subsequent assignment of conductivities from published values. [17] Currently available segmentation software is either semi- or full-automatic. [18] While this method is fairly straight- forward, it does not account for variation of a given tissue between individuals or for conductivity changes within the same tissue. [19] Furthermore, partial-volume effects (that occur when multiple tissue types contribute to the same voxel) may lead to ambiguities in tissue-type assignment. Finally, some tissue types have a wide range of published conductivities possibly due to differences in hydration, individual variation in the properties of a given tissue, or measurement inaccuracies. Significant errors in the conductivity map may result if the wrong values are applied.
  • the anatomical images may be converted directly into a conductivity map.
  • the images acquired using MRI are converted directly into a conductivity map.
  • the intensity of a single pixel is dependent on both Tl, the spin-lattice relaxation time, and T2, the spin-spin relaxation time. Since Tl is related to water content, if the contribution of Tl to the signal intensity is isolated (by using methods such as those proposed by Mazzurana et al) we may determine the water content of each voxel. [20] The conductivity of each voxel may then be determined from its water content using published methods. [21] Fat and cortical bone generate significant contrast despite their low water permittivity values.
  • the patient's CT scans may be converted directly into a conductivity map.
  • X-ray absorption is correlated with the density of the tissue through which the X-ray has passed. Consequently, more dense tissues such as bone appear white, whereas less dense tissues such as the heart appear in shades of gray, and air-filled sacs within the lung appear almost black.
  • a conductivity value for each pixel may be retrieved from its corresponding tissue density value.
  • the patient's ultrasound scans may be converted directly into a conductivity map.
  • the grayscale value of an ultrasound image pixel depends on the intensity of the signal reflection from that pixel. Pixels corresponding to an interface between tissues with significantly different abilities to transmit sound will appear bright on the ultrasound image. On the other hand, pixels corresponding to an area of general homogeneity will be dark. Since different tissues are characterized by different inhomogeneities, they will each scatter differently; it may be possible to use the resulting signal intensity to assign pixel conductivities automatically.
  • the two methods for creating conductivity maps are combined by using margins around published values to constrain the tissue conductivity we estimate from the image signal.
  • margins around published values to constrain the tissue conductivity we estimate from the image signal.
  • the electrical activity due to currents consecutively injected by the Body Electrodes is then simulated at a plurality of locations.
  • a set of two Body Electrodes is simulated to lie at pre-defined locations on the body, and the potentials that would result inside the region of the body from current flow between them are modeled.
  • the current flow at each location must be calculated in order to determine the potential at each location. Current flows under the current electrodes are well-defined.
  • the torso volume may be initially partitioned into a coarse grid of volume elements of dimension greater than 1 cm.
  • the conductivity of each volume element is approximated by averaging the conductivities of all the locations contained within it.
  • the potentials at the centers of every volume element are then calculated in parallel using Eqns. 2 and 3, and these calculations are iterated on until the potentials converge to a pre-defined end- point.
  • the volume element size may be halved in each dimension, and the potentials from the coarser grid 'projected' onto the finer grid.
  • the potentials at this finer resolution are then iterated on until they converge, the grid dimensions are halved, and so on, until the resolution of the calculations is the same as the resolution of the anatomical images taken.
  • each location within the MRI image is defined by a unique 'voltage triplet ', in which each member of the triplet is the voxel potential resulting from the flow of current between the electrodes in one set.
  • this simulated activity is saved (for instance, in the form of a 'look-up table').
  • Body Electrodes with skin-contact dimensions that would ideally be on the order of the resolution of the anatomical image are placed at the locations used in the simulations, and the surgical instrument is inserted subcutaneously.
  • the simulated electrical activity at a plurality of locations is compared with the electrical activity detected by the one or more Object Electrodes.
  • the location with the 'most similar' simulated electrical activity to that detected by each Object Electrode may then be defined as the location of that Object Electrode.
  • the instrument location may be identified in real-time. ' Similarity' may be assessed using one or more measures that compare the recorded electrical activity to the simulated electrical activity.
  • knowledge of the electrical activity detected by the one or more Object Electrodes is used to improve the accuracy of the simulation.
  • the method's accuracy relies on the accurate simulation of electrical activity in a region of the body, such that the measured electrical activity at any location will be highly similar to the simulated electrical activity at that location.
  • small inaccuracies in the assigned conductivity values and limitations in the current flow model may lead to sub-optimal look up table accuracy.
  • knowledge of the electrical activity detected by the one or more Object Electrodes may be recorded and used to improve the accuracy of the simulation.
  • the locations of the one or more Object Electrodes are displayed on a graphical user interface.
  • the displayed locations of the one or more Object Electrodes may be superimposed on an image of a region of the body.
  • the ability to superimpose object locations on a high-resolution, detailed anatomical map of the region of the body is one of the great advantages of the current invention.
  • FIG. 3 shows a preferred embodiment of the apparatus for localizing an object inside the body, after an image has been taken of the region of the body, the regional electrical conductivity has been approximated, and the regional electrical activity has been calculated.
  • a plurality of Body Electrode pairs (1 and 1 ', 2 and 2', 3 and 3') are placed on a region of the body 4 such that the region of the body may be viewed from several sides, and in the same locations as those used in the simulations of electrical activity.
  • the Body Electrodes need not be arrayed such that the signals between each pair are orthogonal. Each electrode position is provided by the operator to the analysis software.
  • the Body Electrodes are connected via a multi-lead cable 7 through a high- voltage isolation stage 6 to a signal generator 5, which is controlled by a computer 12 and can generate currents between each of the Body Electrode pairs in turn.
  • the current magnitude should be of sufficient amplitude to create a significant potential gradient across the region of the body, but of small enough amplitude to be safe to apply to the patient (e.g. 1 mA).
  • Signals from the one or more Object Electrodes 9 on the object 8 are carried in a cable 14 through an isolation amplifier 10 to an amplifier 11 with adjustable gain and frequency response.
  • the computer 12 equipped with an analog to digital conversion card digitizes, processes and records the signals detected by the Object Electrodes.
  • the location of the Object is found by comparing the signals detected by the Object Electrodes with the simulated electrical activity at a plurality of locations. The location with the 'most similar' simulated electrical activity to that detected by each Object Electrode may then be defined as the location of that Object Electrode.
  • the computer 12 displays the calculated location of the Object Electrode on a display 13. The displayed locations of the one or more Object Electrodes may be superimposed on a displayed image of the region of the body.
  • FIG. 4 shows a simulation model that demonstrates a simple example of our method to localize an object in the volume conductor.
  • the volume conductor A is modeled here as a homogenous cube, containing a spherical hollow 'organ' B of a different conductivity centered in the middle of the cube (a cross-section of the hollow organ is also provided in FIG. 4).
  • the conductivity of the homogenous cube was chosen to be 0.001 Q 4 Cm "1 and the conductivity of the spherical organ was 0.004 Q 1 Cm "1 .
  • Body Electrodes were simulated at six locations on the volume conductor surface. A current of ImA was applied through each pair of the simulated Body Electrodes in turn.
  • FIG. 4 One set of Body Electrodes (D and D') is shown in FIG. 4.
  • the simulated voltages for this pair of surface Body Electrodes is shown in FIG. 5.
  • the figure shows a horizontal (x-y) slice through the center of the volume conductor, with the simulated voltage values for the voxels within that slice displayed on the z-axis. It has been found using this and other volume conductor models that each voxel in a region of the volume conductor (for instance within the hollow spherical organ in FIG. 3) is defined by a unique set of voltages if three or more injected currents are used.
  • V 1I is the potential of voxel i due to Body Electrode pair 1
  • V 12 is the potential of voxel i due to Body Electrode pair 2, etc.
  • the noise expected in a hospital setting in the frequency range of 10-20 kHz is on the order of 10 ⁇ V or less.
  • environmental shielding is a possibility for frequencies in the range of 10 kHz. Consequently, even in the presence of the noise expected in a hospital environment, each voxel should have a uniquely identifiable voltage triplet. We should therefore be able to resolve the position of the catheter tip to the same resolution as the anatomical image (i.e. 2 mm or less).
  • the invention's method to simulated current flow has also been tested by simulating the 'four electrode technique'.
  • This technique has been used in many studies to measure the conductivity of excised tissue.
  • frequency-dependent polarization generates a counter voltage at the electrode tips. Consequently, the resistance measured between the electrodes reflects not only the tissue but also the electrode -tissue interface.
  • the effect of the interface is removed by using four electrodes arranged so that their tips touch the tissue at four equally spaced points along a straight line: two outer electrodes for current injection, and two inner electrodes for voltage measurement. Needle electrodes are used so that a point-source approximation can be made.
  • the voltage difference measured is related to the tissue conductivity by a well established relationship. If the tissue is homogenous and its dimensions are large enough such that boundary effects are negligible, the tissue's conductivity can be estimated from the measured voltage difference by a well-established relationship.
  • ⁇ ca ⁇ c is the tissue conductivity between the electrodes
  • / is the current injected
  • d is the distance between two adjacent electrodes. Therefore, one measure of the ability of the present invention to simulate a realistic experimental setting is how similar the value of ⁇ ca ⁇ c is to the actual value of ⁇ for a simulated homogenous model.
  • the present invention has been found to produce values of ⁇ ca ⁇ c less than 0.1% different from the actual value. This is a highly successful preliminary test of the accuracy of our current flow model. Therefore, testing has indicated that the present invention may be used to localize an object inside a region of the body in real-time and with high accuracy.
  • the present invention differs significantly from the LocaLisa positioning system.
  • Localisa is a non-fluoroscopic catheter positioning system that allows a conventional catheter to be located within the heart in three dimensions. It utilizes three orthogonal (or nearly-orthogonal) electric fields, generated across the body by sets of skin electrodes. For calibration purposes, Localisa calculates the electrical field strength due to each applied current within the cardiac chamber of interest, assuming that the electrical field due to the applied current is constant across the body (and especially within the chamber of interest).
  • the 3-D position of the tip electrode relative to a surface reference electrode is then calculated, by first measuring the amplitudes at the catheter tip relative to a surface reference electrode due to the three orthogonal electric fields, and then dividing these three amplitudes by the corresponding electrical field strengths (calculated during calibration).
  • torso inhomogeneities are not taken into account, no conductivity map is generated, and electrical activity due to the applied currents is not simulated. This leads to substantial degradation in accuracy of localization and overall performance of the system.
  • near-orthogonality of the applied currents is crucial to Localisa' s accuracy.
  • the present invention places no such restriction on the placement of the surface electrodes.
  • Stability of the surface reference electrode is also vital to the accuracy of the Localisa system; the present invention utilizes no such reference and so does not suffer from this drawback. Furthermore, because this method falsely assumes a homogenous 3D electrical field within the entire body cavity, errors at positions more than a few centimeters from the location of calibration may be on the order of 8 mm. The severity of these errors, and the measurement of the catheter position in co-ordinates relative to a reference point, prevents the positional data from being superimposed on a detailed image of the surgical region. The present invention, on the other hand, will yield a much higher accuracy and allow superposition of an image of the surgical instrument onto a high-resolution image of the surgical region.
  • both Localisa and the present invention require the injection of currents by surface electrodes to image the location of the surgical instrument, they differ significantly in the requirements placed on the system, in how the applied currents are used to calculate the instrument location, in the accuracy of the calculated location, and in the presentation of the information.
  • FIG 6 shows a flowchart of the method according to the present invention of localizing an object inside the body when the frequency of the current applied to the Body Electrodes is greater than 50 kHz.
  • the method includes applying a plurality of Body Electrodes to the body, and introducing one or more objects containing one or more conducting Object Electrodes into the region of the body. Electrical currents with a frequency of greater than 50 kHz (so as to reduce the anisotropy of body tissues) are then applied to the Body Electrodes and the electrical activity that results within the body is detected by the Object Electrodes and recorded. The recorded electrical activity is then used to estimate the locations of the one or more Object Electrodes.
  • the anisotropy of the electrical properties, such as electrical conductivity, of body tissues can reduce the accuracy of the localization if not compensated for.
  • the anisotropy of electrical properties of various tissues is explicitly accounted for in calculating the simulated electrical activity.
  • the frequency of the applied electrical currents is elevated above 50 kHz in order to reduce the magnitude of the anisotropy of the electrical properties of various tissues.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Human Computer Interaction (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

L'invention concerne un procédé et un appareil permettant en temps réel et en trois dimensions un guidage par image d'outils invasifs chirurgicaux de diagnostic et de thérapie. Dans ce procédé, la distribution tridimensionnelle de la conductivité électrique de la zone chirurgicale digne d'intérêt est déduite en utilisant les images provenant de la tomographie assistée par ordinateur (CT) par rayons X d'une imagerie par résonance magnétique (IRM), ou d'autres techniques. Le courant circule et les tensions dans la zone dues aux courants appliqués depuis les électrodes de la surface du corps aux emplacements définis sont simulées en utilisant un procédé par élément fini. Pendant l'intervention chirurgicale, des électrodes sont placées aux mêmes emplacements, et l'instrument chirurgical est inséré dans la zone. En faisant correspondre les potentiels mesurés par l'instrument aux potentiels simulés, l'emplacement de l'instrument peut être identifié en temps réel.
PCT/US2007/080250 2006-10-16 2007-10-03 Procédé et appareil permettant de localiser un objet dans le corps Ceased WO2008048780A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/445,668 US20100283484A1 (en) 2006-10-16 2007-10-03 Method and Apparatus for Localizing an Object in the Body

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85209306P 2006-10-16 2006-10-16
US60/852,093 2006-10-16

Publications (1)

Publication Number Publication Date
WO2008048780A1 true WO2008048780A1 (fr) 2008-04-24

Family

ID=39079603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/080250 Ceased WO2008048780A1 (fr) 2006-10-16 2007-10-03 Procédé et appareil permettant de localiser un objet dans le corps

Country Status (2)

Country Link
US (1) US20100283484A1 (fr)
WO (1) WO2008048780A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8712138B2 (en) 2009-10-13 2014-04-29 Koninklijke Philips N.V. Device and method for generating soft tissue contrast images
US10506948B2 (en) 2011-07-05 2019-12-17 Cardioinsight Technologies, Inc. Localization for electrocardiographic mapping

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9307925B2 (en) 2005-06-16 2016-04-12 Aaken Laboratories Methods and systems for generating electrical property maps of biological structures
US8855396B2 (en) 2010-05-25 2014-10-07 Siemens Medical Solutions Usa, Inc. System for detecting an invasive anatomical instrument
US9763587B2 (en) * 2010-06-10 2017-09-19 Biosense Webster (Israel), Ltd. Operator-controlled map point density
DE102015202151A1 (de) * 2015-02-06 2016-01-28 Siemens Aktiengesellschaft Verfahren und Vorrichtung zum Erstellen einer Karte eines Reizleitverhaltens eines Herzmuskels
EP3294127A1 (fr) 2015-05-12 2018-03-21 Navix International Limited Systèmes et procédés de suivi d'un cathéter intracorps
EP3294174B1 (fr) 2015-05-12 2022-12-14 Navix International Limited Évaluation d'une qualité de contact par analyse de propriétés diélectriques
CN107635503B (zh) 2015-05-12 2021-09-07 纳维斯国际有限公司 通过介电性质分析进行损伤估计
US11039888B2 (en) 2015-05-12 2021-06-22 Navix International Limited Calculation of an ablation plan
US20160354049A1 (en) * 2015-06-04 2016-12-08 Biosense Webster (Israel) Ltd. Registration of coronary sinus catheter image
US11350996B2 (en) * 2016-07-14 2022-06-07 Navix International Limited Characteristic track catheter navigation
US11284813B2 (en) 2016-11-16 2022-03-29 Navix International Limited Real-time display of tissue deformation by interactions with an intra-body probe
WO2018092070A1 (fr) 2016-11-16 2018-05-24 Navix International Limited Détection de position de l'œsophage par cartographie électrique
CN110177500B (zh) 2016-11-16 2022-03-04 纳维斯国际有限公司 组织模型动态视觉渲染
US11622713B2 (en) 2016-11-16 2023-04-11 Navix International Limited Estimators for ablation effectiveness
WO2018092063A1 (fr) 2016-11-16 2018-05-24 Navix International Limited Affichage en temps réel de changements de tissu liés au traitement à l'aide d'un matériau virtuel
US20250152250A1 (en) * 2023-11-10 2025-05-15 Ablacon Inc. Controlled Constant Current Systems, Devices, Components and Methods for Navigating, Positioning, and/or Imaging a Medical Device Inside a Patient's Body

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5697377A (en) * 1995-11-22 1997-12-16 Medtronic, Inc. Catheter mapping system and method
US20060241401A1 (en) * 2005-01-07 2006-10-26 Assaf Govari Reference catheter for impedance calibration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6397095B1 (en) * 1999-03-01 2002-05-28 The Trustees Of The University Of Pennsylvania Magnetic resonance—electrical impedance tomography
US6650927B1 (en) * 2000-08-18 2003-11-18 Biosense, Inc. Rendering of diagnostic imaging data on a three-dimensional map
US7850610B2 (en) * 2004-06-28 2010-12-14 Medtronic, Inc. Electrode location mapping system and method
US7869865B2 (en) * 2005-01-07 2011-01-11 Biosense Webster, Inc. Current-based position sensing
DE102005045093A1 (de) * 2005-09-21 2007-04-05 Siemens Ag Verfahren zur Lokalisation eines in den Körper eines Untersuchungsobjekts eingeführten medizinischen Instruments
US7511492B2 (en) * 2006-02-21 2009-03-31 Beth Israel Deaconess Medical Center, Inc. Magnetic resonance imaging and radio frequency impedance mapping methods and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5697377A (en) * 1995-11-22 1997-12-16 Medtronic, Inc. Catheter mapping system and method
US20060241401A1 (en) * 2005-01-07 2006-10-26 Assaf Govari Reference catheter for impedance calibration

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BECKER RUEDIGER ET AL: "Ablation of atrial fibrillation: energy sources and navigation tools: a review.", JOURNAL OF ELECTROCARDIOLOGY 2004, vol. 37 Suppl, 2004, pages 55 - 62, XP004623082, ISSN: 0022-0736 *
MARKIDES VIAS ET AL: "New mapping technologies: an overview with a clinical perspective.", JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY : AN INTERNATIONAL JOURNAL OF ARRHYTHMIAS AND PACING AUG 2005, vol. 13 Suppl 1, August 2005 (2005-08-01), pages 43 - 51, XP019208602, ISSN: 1383-875X *
MAYA BARLEY: "Bioelectrical Strategies for Image-Guided Therapies", 14 May 2007, COHEN LAB, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, E25-119, XP002470151 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8712138B2 (en) 2009-10-13 2014-04-29 Koninklijke Philips N.V. Device and method for generating soft tissue contrast images
US10506948B2 (en) 2011-07-05 2019-12-17 Cardioinsight Technologies, Inc. Localization for electrocardiographic mapping

Also Published As

Publication number Publication date
US20100283484A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
US20100283484A1 (en) Method and Apparatus for Localizing an Object in the Body
AU2020200911B2 (en) Registration maps using intra-cardiac signals
CN109419501B (zh) 用于检测电流位置标测图(cpm)标测中的孔的高级电流位置(acl)自动标测图旋转
CA2747859C (fr) Dispositif et procede permettant la determination geometrique de densites de dipole electrique sur la paroi cardiaque
CN102036606B (zh) 测绘结构的方法和装置
JP5111762B2 (ja) 電流に基づく位置探知
AU2014265090B2 (en) Tracking of catheter from insertion point to heart using impedance measurements
JP5306617B2 (ja) 心臓電位分布図の体表面測定値との相関
US7141019B2 (en) Tissue characterization based on impedance images and on impedance measurements
US6421559B1 (en) Tissue characterization based on impedance images and on impedance measurements
US7778689B2 (en) Method for localizing a medical instrument introduced into the body of an examination object
WO2005057467A2 (fr) Caracterisation tissulaire par sonde a courants de foucault
KR20020014751A (ko) 3차원 맵상에 진단 영상 데이타를 묘사하는 방법 및 장치
US20150320515A1 (en) System and methods for using body surface cardiac electrogram information combined with internal information to deliver therapy
JP6872625B2 (ja) 電気生理学的マッピング中に脂肪組織を瘢痕組織から区別するためのシステム及びその作動方法
US20090088633A1 (en) Method for the combined image display of a catheter inserted into the heart area of a patient with electrophysiological cardiological data
AU2016274615B2 (en) Non-invasive system and method of spatial localization of specific electrocardiac elements
Wilson et al. Mapping of cardiac electrophysiology onto a dynamic patient-specific heart model
Agren et al. Magnetocardiographic localization of arrhythmia substrates: a methodology study with accessory pathway ablation as reference
Barley Bioelectrical strategies for image-guided therapies
CN119300773A (zh) 从三维超声图像裁剪感兴趣区域的体积图像

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07843708

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07843708

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12445668

Country of ref document: US